Skip to main content
77°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Medexus Pharmaceuticals Inc
Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
April 18, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
April 11, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus Announces New License Deal for Topical Terbinafine
March 22, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus Announces US$58.5 million in New Credit Facilities
March 08, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus to Participate in 35th Annual Roth Conference
March 06, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
February 08, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus Welcomes Two New Board Members
February 06, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus Secures Public Reimbursement for Cuvposa® in Quebec
February 01, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
January 31, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
January 12, 2023
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022
November 08, 2022
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus Schedules Second Quarter 2023 Conference Call
November 02, 2022
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023
October 06, 2022
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Medexus and MidCap Agree to Increase in MidCap’s Revolving Loan Commitment Amount
September 29, 2022
From
Medexus Pharmaceuticals Inc
Via
GlobeNewswire
Tickers
MEDXF
TSX:MDP
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.